148 related articles for article (PubMed ID: 9432753)
1. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
Weisser H; Krieg M
Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
[TBL] [Abstract][Full Text] [Related]
2. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
[TBL] [Abstract][Full Text] [Related]
3. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
[TBL] [Abstract][Full Text] [Related]
4. 17 beta-hydroxysteroid oxidoreductase in epithelium and stroma of human prostate.
Tunn S; Schulze H; Krieg M
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):91-101. PubMed ID: 7687861
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
Weisser H; Krieg M
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):49-55. PubMed ID: 9780029
[TBL] [Abstract][Full Text] [Related]
6. Potential activities of androgen metabolizing enzymes in human prostate.
Krieg M; Weisser H; Tunn S
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
[TBL] [Abstract][Full Text] [Related]
7. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
Krieg M; Nass R; Tunn S
J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
[TBL] [Abstract][Full Text] [Related]
8. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
[TBL] [Abstract][Full Text] [Related]
10. 5 alpha-androstane-3 beta,17 beta-diol hydroxylating enzymes in stroma and epithelium of human benign prostatic hyperplasia (BPH).
Tunn S; Claus S; Schulze H; Braun BE; Krieg M
J Steroid Biochem; 1987 Sep; 28(3):257-65. PubMed ID: 2443760
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
12. 5 alpha-reductase activity in epithelium and stroma of prostates from intact and castrated dogs treated with androstenedione, the aromatase inhibitor 1-methyl-1,4-androstadiene-3,17-dione, and cyproterone acetate.
Tunn S; Hochstrate H; Habenicht UF; Krieg M
Prostate; 1988; 12(3):243-53. PubMed ID: 2967468
[TBL] [Abstract][Full Text] [Related]
13. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
Hudson RW; Wherrett D
J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol.
Krieg M; Schlenker A; Voigt KD
Prostate; 1985; 6(3):233-40. PubMed ID: 2581234
[TBL] [Abstract][Full Text] [Related]
16. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
[TBL] [Abstract][Full Text] [Related]
17. 5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia.
Weisser H; Tunn S; Debus M; Krieg M
Steroids; 1994 Nov; 59(11):616-20. PubMed ID: 7535480
[TBL] [Abstract][Full Text] [Related]
18. [Benign prostatic hyperplasia--the outcome of age-induced alteration of androgen-estrogen balance?].
Weisser H; Krieg M
Urologe A; 1997 Jan; 36(1):3-9. PubMed ID: 9123678
[TBL] [Abstract][Full Text] [Related]
19. Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo.
Weisser H; Behnke B; Helpap B; Bach D; Krieg M
Eur Urol; 1997; 31(1):97-101. PubMed ID: 9032543
[TBL] [Abstract][Full Text] [Related]
20. In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
Lombardo ME; Hakky SI; Hall MK; Hudson PB
J Urol; 1992 Nov; 148(5):1605-10. PubMed ID: 1279222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
